QurAlis

Last updated: October 10, 2024

Kevin Eggan, Co-Founder
Kevin Eggan, Co-Founder
USA | Funding: $135.5M (+)

Website: https://quralis.com/

QurAlis is specifically focused on discovering & developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.